A
Price
$123.38
Change
+$1.49 (+1.22%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
34.56B
66 days until earnings call
VCYT
Price
$33.44
Change
+$0.62 (+1.89%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
2.58B
46 days until earnings call
Interact to see
Advertisement

A vs VCYT

Header iconA vs VCYT Comparison
Open Charts A vs VCYTBanner chart's image
Agilent Technologies
Price$123.38
Change+$1.49 (+1.22%)
Volume$3.08K
Capitalization34.56B
Veracyte
Price$33.44
Change+$0.62 (+1.89%)
Volume$20.33K
Capitalization2.58B
A vs VCYT Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. VCYT commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and VCYT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (A: $123.38 vs. VCYT: $33.44)
Brand notoriety: A and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 23% vs. VCYT: 15%
Market capitalization -- A: $34.56B vs. VCYT: $2.58B
A [@Medical Specialties] is valued at $34.56B. VCYT’s [@Medical Specialties] market capitalization is $2.58B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 6 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 6 bullish, 4 bearish.
  • VCYT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, A is a better buy in the short-term than VCYT.

Price Growth

A (@Medical Specialties) experienced а -2.33% price change this week, while VCYT (@Medical Specialties) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.12%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +24.86%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Specialties (-0.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($34.6B) has a higher market cap than VCYT($2.58B). VCYT has higher P/E ratio than A: VCYT (96.53) vs A (28.48). A YTD gains are higher at: -8.883 vs. VCYT (-15.556). A has higher annual earnings (EBITDA): 1.8B vs. VCYT (52M). A has more cash in the bank: 1.54B vs. VCYT (321M). VCYT has less debt than A: VCYT (50.6M) vs A (3.41B). A has higher revenues than VCYT: A (6.79B) vs VCYT (479M).
AVCYTA / VCYT
Capitalization34.6B2.58B1,340%
EBITDA1.8B52M3,456%
Gain YTD-8.883-15.55657%
P/E Ratio28.4896.5330%
Revenue6.79B479M1,417%
Total Cash1.54B321M478%
Total Debt3.41B50.6M6,737%
FUNDAMENTALS RATINGS
A vs VCYT: Fundamental Ratings
A
VCYT
OUTLOOK RATING
1..100
7519
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
4589
PRICE GROWTH RATING
1..100
5447
P/E GROWTH RATING
1..100
4760
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (52) in the Biotechnology industry is in the same range as VCYT (75). This means that A’s stock grew similarly to VCYT’s over the last 12 months.

A's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as VCYT (100). This means that A’s stock grew similarly to VCYT’s over the last 12 months.

A's SMR Rating (45) in the Biotechnology industry is somewhat better than the same rating for VCYT (89). This means that A’s stock grew somewhat faster than VCYT’s over the last 12 months.

VCYT's Price Growth Rating (47) in the Biotechnology industry is in the same range as A (54). This means that VCYT’s stock grew similarly to A’s over the last 12 months.

A's P/E Growth Rating (47) in the Biotechnology industry is in the same range as VCYT (60). This means that A’s stock grew similarly to VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVCYT
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
62%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
60%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIIEX15.31N/A
N/A
Optimum International Instl
EICIX19.06N/A
N/A
EIC Value Institutional
DHPAX18.12N/A
N/A
Diamond Hill Mid Cap Inv
OAYMX165.62N/A
N/A
Oakmark Advisor
HLSCX22.52N/A
N/A
Hartford Disciplined Equity HLS IC

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-2.00%
MTD - A
85%
Closely correlated
-2.64%
TMO - A
79%
Closely correlated
-1.88%
WAT - A
79%
Closely correlated
-1.66%
RVTY - A
78%
Closely correlated
-1.72%
DHR - A
75%
Closely correlated
-2.39%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been loosely correlated with GH. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VCYT jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+1.89%
GH - VCYT
53%
Loosely correlated
-0.30%
NTRA - VCYT
53%
Loosely correlated
-0.42%
TWST - VCYT
51%
Loosely correlated
+0.64%
ILMN - VCYT
50%
Loosely correlated
-0.55%
A - VCYT
49%
Loosely correlated
+1.22%
More